Alvotech In-Licenses Xolair Rival From BiosanaPharma
Co-Development Deal Will See Pair Collaborate On Omalizumab Biosimilar
Alvotech has delivered on indications that it would look to collaborate on certain biosimilar opportunities in future, striking a licensing deal with BiosanaPharma that will see the two firms partner to co-develop an omalizumab biosimilar rival to Xolair.
